TYME Tyme Technologies Inc

Tyme Technologies Inc is a clinical-stage pharmaceutical company focused on discovering and developing targeted cancer therapeutics for a broad range of oncology indications. The Company is developing proprietary combination drug product.

$1.29
As of 06/24/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/11/2018
Outstanding shares:  172,206,894
Average volume:  3,557,900
Market cap:   $227,313,100
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    90238J103
ISIN:        US90238J1034
Sedol:      BR3HZM3
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   19.85
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy